Case report
First in Human Totally Endoscopic Perceval Valve Implantation

https://doi.org/10.1016/j.athoracsur.2016.03.045Get rights and content

Totally endoscopic cardiac operations for coronary procedures and atrial septal defect repair have demonstrated improved quality of life, but they have required longer cross-clamp times compared with open operations. Although transcatheter valve implantation remains appropriate for inoperable patients, the totally endoscopic approach could be an effective treatment for lower risk patients, including complete removal of the stenotic aortic valve, while minimizing surgical chest wall trauma, and providing excellent early quality of life. Totally endoscopic aortic valve replacement procedures were previously performed with the 3f Enable bioprosthesis. We present the first case, to our knowledge, of Sorin Perceval implantation.

Section snippets

Comment

Closed chest cardiac operation has demonstrated excellent outcomes but with longer cross-clamp times compared with open approaches [2]. Our initial experience with TEAVR is consistent with previous experience, because the mean cross-clamp and CPB times were 112 ± 18 and 161 ± 31 minutes, respectively, in a 14-patient feasibility series with the use of the 3f Enable (Medtronic) sutureless prosthesis. However, the 3f Enable valve required a complex technique of positioning; the stent was kept

References (6)

There are more references available in the full text version of this article.

Cited by (10)

View all citing articles on Scopus
View full text